Brawn Biotech Ltd

BOM:530207 (India)  
₹ 26.80 (0%) Jun 21
At Loss
P/B:
1.59
Market Cap:
₹ 80.41M ($ 963.00K)
Enterprise V:
₹ 65.28M ($ 782.00K)
Volume:
100.00
Avg Vol (2M):
1.42K
Trade In:
Volume:
100.00
At Loss
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Brawn Biotech Ltd ( ) from 2000 to Jun 24 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Brawn Biotech stock (BOM:530207) PE ratio as of Jun 24 2024 is 0. More Details

Brawn Biotech Ltd (BOM:530207) PE Ratio (TTM) Chart

To

Brawn Biotech Ltd (BOM:530207) PE Ratio (TTM) Historical Data

Total 1279
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 15
Brawn Biotech PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-24 At Loss 2024-04-23 At Loss
2024-06-21 At Loss 2024-04-22 At Loss
2024-06-20 At Loss 2024-04-19 At Loss
2024-06-19 At Loss 2024-04-18 At Loss
2024-06-18 At Loss 2024-04-17 At Loss
2024-06-17 At Loss 2024-04-16 At Loss
2024-06-14 At Loss 2024-04-15 At Loss
2024-06-13 At Loss 2024-04-12 At Loss
2024-06-12 At Loss 2024-04-11 At Loss
2024-06-11 At Loss 2024-04-10 At Loss
2024-06-10 At Loss 2024-04-09 At Loss
2024-06-07 At Loss 2024-04-08 At Loss
2024-06-06 At Loss 2024-04-05 At Loss
2024-06-05 At Loss 2024-04-04 At Loss
2024-06-04 At Loss 2024-04-03 At Loss
2024-06-03 At Loss 2024-04-02 At Loss
2024-05-31 At Loss 2024-04-01 At Loss
2024-05-30 At Loss 2024-03-29 At Loss
2024-05-29 At Loss 2024-03-28 At Loss
2024-05-28 At Loss 2024-03-27 At Loss
2024-05-27 At Loss 2024-03-26 At Loss
2024-05-24 At Loss 2024-03-25 At Loss
2024-05-23 At Loss 2024-03-22 At Loss
2024-05-22 At Loss 2024-03-21 At Loss
2024-05-21 At Loss 2024-03-20 At Loss
2024-05-20 At Loss 2024-03-19 At Loss
2024-05-18 At Loss 2024-03-18 At Loss
2024-05-17 At Loss 2024-03-15 At Loss
2024-05-16 At Loss 2024-03-14 At Loss
2024-05-15 At Loss 2024-03-13 At Loss
2024-05-14 At Loss 2024-03-12 At Loss
2024-05-13 At Loss 2024-03-11 At Loss
2024-05-10 At Loss 2024-03-08 At Loss
2024-05-09 At Loss 2024-03-07 At Loss
2024-05-08 At Loss 2024-03-06 At Loss
2024-05-07 At Loss 2024-03-05 At Loss
2024-05-06 At Loss 2024-03-04 At Loss
2024-05-03 At Loss 2024-03-01 At Loss
2024-05-02 At Loss 2024-02-29 At Loss
2024-05-01 At Loss 2024-02-28 At Loss
2024-04-30 At Loss 2024-02-27 At Loss
2024-04-29 At Loss 2024-02-26 At Loss
2024-04-26 At Loss 2024-02-23 At Loss
2024-04-25 At Loss 2024-02-22 At Loss
2024-04-24 At Loss 2024-02-21 At Loss

Brawn Biotech Ltd (BOM:530207) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Brawn Biotech Ltd is a healthcare company. It is primarily engaged in the business activity of wholesale of pharmaceutical and medical goods. The company's pharmaceutical goods cover product segments like Antibacterial, Cardiovascular, Anti-diabetic, Analgesics, Gastrointestinal, Antifungals, Skin Care, Antipsychotics, Anti-asthmatic, Antacids, Antimalarial, and Nutritionals. It markets pharmaceutical products in India and internationally. The company generates a major portion of its revenue from exports.